SS
Sandeep Singh
About Sandeep Singh
Data last updated:
Sandeep Singh is a Director at Noverax Lifescience Private Limited (since 2025), Director at Noverax Healthcare (Opc) Private Limited (since 2021) and Director at Alderon Pharmaceutical Private Limited (since 2016). The companies operate in Chemicals and Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Feb 2025 | 2025 | Active | ||
| Director | 28 Oct 2021 | 2021 | Active | ||
| Director | 21 Mar 2016 | 2016 | Active |
Board colleagues of Sandeep Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satyapal Singh | 10869010 | Noverax Lifescience Private Limited , Alderon Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandeep Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandeep Singh
Sandeep Singh currently holds 3 directorships: Noverax Lifescience Private Limited (Director, since 06 Feb 2025); Noverax Healthcare (Opc) Private Limited (Director, since 28 Oct 2021); Alderon Pharmaceutical Private Limited (Director, since 21 Mar 2016).
Sandeep Singh was first appointed on 21 Mar 2016 as Director at Alderon Pharmaceutical Private Limited. The most recent appointment on record is 06 Feb 2025 at Noverax Lifescience Private Limited.
The current boards of Sandeep Singh's companies include Satyapal Singh (Noverax Lifescience Private Limited).